Mitsubishi Tanabe Pharma:Clinical Trial Information http://www.mt-pharma.co.jp/e/develop/protocol.php ja [Clinical Trial Information] A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With http://www.mt-pharma.co.jp/e/develop/protocol.php#20120123000049 [Clinical Trial Information] Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis http://www.mt-pharma.co.jp/e/develop/protocol.php#20111216000048 [Clinical Trial Information] Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients http://www.mt-pharma.co.jp/e/develop/protocol.php#20111110000047 [Clinical Trial Information] Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Genotype 2 Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy http://www.mt-pharma.co.jp/e/develop/protocol.php#20111108000046 [Clinical Trial Information] A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis http://www.mt-pharma.co.jp/e/develop/protocol.php#20110831000045 [Clinical Trial Information] Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20110817000044 [Clinical Trial Information] Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus http://www.mt-pharma.co.jp/e/develop/protocol.php#20110707000043 [Clinical Trial Information] Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20110224000042 [Clinical Trial Information] Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis http://www.mt-pharma.co.jp/e/develop/protocol.php#20100615000041 [Clinical Trial Information] Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus http://www.mt-pharma.co.jp/e/develop/protocol.php#20100224000040 [Clinical Trial Information] Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20091207000039 [Clinical Trial Information] An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20091202000038 [Clinical Trial Information] Monotherapy Study of MP-513 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20091029000037 [Clinical Trial Information] Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20090911000036 [Clinical Trial Information] Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20090911000035 [Clinical Trial Information] Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia http://www.mt-pharma.co.jp/e/develop/protocol.php#20090318000034 [Clinical Trial Information] Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II http://www.mt-pharma.co.jp/e/develop/protocol.php#20090316000033 [Clinical Trial Information] Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis http://www.mt-pharma.co.jp/e/develop/protocol.php#20090313000032 [Clinical Trial Information] Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke http://www.mt-pharma.co.jp/e/develop/protocol.php#20090115000031 [Clinical Trial Information] Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) http://www.mt-pharma.co.jp/e/develop/protocol.php#20081216000030 [Clinical Trial Information] Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C http://www.mt-pharma.co.jp/e/develop/protocol.php#20081111000029 [Clinical Trial Information] Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy http://www.mt-pharma.co.jp/e/develop/protocol.php#20081111000028 [Clinical Trial Information] Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy http://www.mt-pharma.co.jp/e/develop/protocol.php#20081111000027 [Clinical Trial Information] Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20081016000025 [Clinical Trial Information] Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke http://www.mt-pharma.co.jp/e/develop/protocol.php#20080821000026 [Clinical Trial Information] Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-Responsive Clinical Pharmacology Study http://www.mt-pharma.co.jp/e/develop/protocol.php#20080821000024 [Clinical Trial Information] Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080821000023 [Clinical Trial Information] Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients http://www.mt-pharma.co.jp/e/develop/protocol.php#20080702000022 [Clinical Trial Information] A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000021 [Clinical Trial Information] A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000020 [Clinical Trial Information] A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000019 [Clinical Trial Information] Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000018 [Clinical Trial Information] A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-Based P Binders in Patients With Hyperphosphatemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000017 [Clinical Trial Information] Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000016 [Clinical Trial Information] A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000015 [Clinical Trial Information] Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000014 [Clinical Trial Information] Post-Marketing Clinical Study of Alteplase for Acute Ischemic Stroke http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000013 [Clinical Trial Information] Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000012 [Clinical Trial Information] Efficacy and Safety Study of GB-0998 for Treatment of Steroid-Resistant Polymyositis and Dermatomyositis (PM/DM) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000011 [Clinical Trial Information] Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis(ALS) http://www.mt-pharma.co.jp/e/develop/protocol.php#20080616000010 [Clinical Trial Information] Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis http://www.mt-pharma.co.jp/e/develop/protocol.php#20080609000008 [Clinical Trial Information] An Extension Study of Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000007 [Clinical Trial Information] A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000006 [Clinical Trial Information] Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000005 [Clinical Trial Information] Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000004 [Clinical Trial Information] Safety and PK Study of MP-424 to Treat Chronic Hepatitis C http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000003 [Clinical Trial Information] Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) http://www.mt-pharma.co.jp/e/develop/protocol.php#20071017000002 [Clinical Trial Information] A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20071015000009 [Clinical Trial Information] A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia http://www.mt-pharma.co.jp/e/develop/protocol.php#20071015000001